Quick Answer
Onconetix, Inc. reported Shares Outstanding of 1.56 million shares for fiscal year 2025.
Onconetix, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 1.56M | +1028.2% |
| 2024 | 138,270 | -75.2% |
| 2023 | 558,099 | -96.3% |
| 2022 | 15.27M | +377.0% |
| 2021 | 3.20M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.56M | -81.2% | +54.7% |
| June 30, 2025 | 1.01M | -95.5% | -97.3% |
| March 31, 2025 | 36.76M | +64.6% | +26486.4% |
| December 31, 2024 | 138,270 | -75.2% | -98.3% |
| September 30, 2024 | 8.31M | -53.3% | -62.8% |
| June 30, 2024 | 22.33M | +36.1% | +0.0% |
| March 31, 2024 | 22.33M | +40.6% | +3900.7% |
| December 31, 2023 | 558,099 | -96.3% | -96.9% |
- Onconetix, Inc. showed an increase of +1028.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, Onconetix, Inc.’s shares outstanding has declined by 51.2% (from 3.20 million shares to 1.56 million shares).
- The most recent figure is from Onconetix, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: